Bombay High Court’s 9 September 2026 order addresses continued admissions at a hospital property despite court directions. Read the verified facts, limits and implications.
A current official explainer of Uttarakhand’s MedLEaPR portal for digital medico-legal and postmortem reporting, with scope, caveats and source dates.
CDC’s 18 September 2026 update lists 3,471 confirmed U.S. measles cases through 17 September. Here is what clinicians, students and travellers in India should understand.
A cautious appraisal of a 2026 Nature Medicine study on adult hippocampal neurogenesis in major depressive disorder.
A practical explanation of CDSCO Not of Standard Quality alerts, batch-level interpretation and safe institutional response.
What the FDA approval of ropeginterferon alfa-2b-njft for adults with essential thrombocythemia means—and what it does not establish in India.
A critical appraisal of a 2026 Nature Medicine study linking histological ageing patterns with molecular and clinical factors.
What FDA guidance says about compounded medicines, quality risks, approved alternatives and the limits of overseas regulatory information.
An evidence-focused explainer of the FDA accelerated approval of sevabertinib, including limitations and India regulatory status.
FDA has approved zilganersen as the first treatment for Alexander disease. Review the mechanism, trial evidence, safety signals and important limitations.
